1.
Wang R, Lu JY, Herbert D, et al. Analysis of schizophrenia-associated genetic markers in the HLA region as risk factors for tardive dyskinesia. Human psychopharmacology. 2024:e2898. doi:10.1002/hup.2898.
1.
Wang R, Lu JY, Herbert D, et al. Analysis of schizophrenia-associated genetic markers in the HLA region as risk factors for tardive dyskinesia. Human psychopharmacology. 2024:e2898. doi:10.1002/hup.2898.
1.
Hivert M-F, Christophi CA, Jablonski KA, et al. Genetic Ancestry Markers and Difference in A1c Between African American and White in the Diabetes Prevention Program. J Clin Endocrinol Metab. 2019;104(2):328-336. doi:10.1210/jc.2018-01416.
1.
Lin W-Y, Chen WJ, Liu C-M, et al. Adaptive combination of Bayes factors as a powerful method for the joint analysis of rare and common variants. Sci Rep. 2017;7(1):13858. doi:10.1038/s41598-017-13177-7.
1.
Green EK, Di Florio A, Forty L, et al. Genome-wide significant locus for Research Diagnostic Criteria Schizoaffective Disorder Bipolar type. Am J Med Genet B Neuropsychiatr Genet. 2017;174(8):767-771. doi:10.1002/ajmg.b.32572.
1.
Udler MS, Kim J, von Grotthuss M, et al. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis. PLoS Med. 2018;15(9):e1002654. doi:10.1371/journal.pmed.1002654.
1.
Kamitaki N, Usher CL, McCarroll SA. Using Droplet Digital PCR to Analyze Allele-Specific RNA Expression. Methods Mol Biol. 2018;1768:401-422. doi:10.1007/978-1-4939-7778-9_23.
1.
Weetman D, Wilding CS, Neafsey DE, et al. Candidate-gene based GWAS identifies reproducible DNA markers for metabolic pyrethroid resistance from standing genetic variation in East African Anopheles gambiae. Sci Rep. 2018;8(1):2920. doi:10.1038/s41598-018-21265-5.
1.
Ruderfer DM, Roberts DC, Schreiber SL, Perlstein EO, Kruglyak L. Using expression and genotype to predict drug response in yeast. PLoS One. 2009;4(9):e6907. doi:10.1371/journal.pone.0006907.
1.
Smith G, Gerszten RE. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease. Circulation. 2017;135(17):1651-1664. doi:10.1161/CIRCULATIONAHA.116.025446.